Skip to main content
. 2017 Apr 10;10(1):59–70. doi: 10.11138/orl/2017.10.1.059

Table 2.

Data at T0.

Patient GI FMPS % FMBS %
Group 1- OILS 1 1.3 81 33
2 1.4 62.5 37
3 1.3 88 34
4 1.2 69 30

Group 2- CLX 1 1.3 66 36
2 1.7 85 61
3 1.8 80 78
4 1.1 63 24

Group 3- TTO 1 1.8 100 69
2 1.6 73 54
3 2 100 77
4 1.7 65 60

Group 4 - Placebo 1 1.6 68 64
2 1.6 55 63
3 1.7 88 60
4 1.4 82 45